Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gross Margin % is calculated as gross profit divided by its revenue. Akumin's Gross Profit for the
three
months ended in Sep. 2023 was C$30.5 Mil. Akumin's Revenue for the
three
months ended in Sep. 2023 was C$244.4 Mil. Therefore, Akumin's Gross Margin % for the quarter that ended in Sep. 2023 was 12.50%.
The historical rank and industry rank for Akumin's Gross Margin % or its related term are showing as below:
TSX:AKU's Gross Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 51.445 * Ranked among companies with meaningful Gross Margin % only.
Akumin had a gross margin of 12.50% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Akumin was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Akumin had a gross margin of 12.50% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Akumin Gross Margin % Related Terms
Akumin Gross Margin % Historical Data
* Premium members only.
The historical data trend for Akumin's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:AKU vs LMDX, CNTG, XGN: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Akumin's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akumin Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Akumin's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Akumin (TSX:AKU) has a Gross Margin % of 12.50% as of Sep. 2023. Gross margin is the ratio of total gross profit to net sales. View historical data on Akumin and its competitors.
Is Akumin's Gross Margin % too high?
Akumin's current Gross Margin % is 12.50%. The Medical Diagnostics & Research industry median Gross Margin % is 51.45. Akumin's value of 12.50% is 75.7% below this industry median. Overall, Akumin has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Akumin's Gross Margin % compare to LMDX and CNTG?
Akumin's Gross Margin % of 12.50% can be compared against companies in the Medical Diagnostics & Research industry. The industry median Gross Margin % is 51.45. Akumin's value of 12.50% is 75.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.45, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Akumin's current Gross Margin % of 12.50% is 75.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Akumin and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akumin's current Gross Margin % is 12.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akumin stock overvalued right now?
Akumin (TSX:AKU) has a current Gross Margin % of 12.50%. The current Gross Margin % is 12.50% and 75.7% below the Medical Diagnostics & Research industry median of 51.45. Akumin's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Akumin (TSX:AKU), the current Gross Margin % is 12.50% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
10GF Score
Get the complete analysis for TSX:AKU
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:AKU has been successfully added to your 
